Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2018

07.02.2018 | Thoracic Oncology

Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?

verfasst von: Ke Jin, MD, Kexi Wang, MD, Huizhong Zhang, MD, Yuejiang Pan, MD, Dexiong Cao, MD, Minghui Wang, MD, Ju Chen, MD, Duoguang Wu, MD, Boshen Chen, MD, Xuan Xie, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Defining the status of solitary pulmonary lesion (SPL) in patients with history of malignancy is important because primary lung cancer (PLC) or intrapulmonary metastasis might indicate different surgical strategies. The aim of this study is to identify factors related to the status of these lesions and construct a clinical model to estimate the pretest probability of PLC.

Methods

From January 2005 to January 2016, 104 patients with previous malignancy and suitable for surgery were retrospectively studied. Univariate and multivariate analyses were performed to identify possible factors related to SPLs. A nomogram was constructed to differentiate PLC from intrapulmonary metastasis.

Results

Ninety-seven (93.3%) patients were diagnosed as malignant postoperatively, including 61 patients with intrapulmonary metastasis and 36 patients with PLC. Multivariate analysis showed that site of primary tumor [head and neck squamous cell cancer: odds ratio (OR) = 28.509, P = 0.006; genitourinary cancer: OR = 23.928, P = 0.012], negative lymph node status of primary tumor (OR = 3.154, P = 0.038), spiculation of SPL (OR = 3.972, P = 0.022), and central location of SPL (OR = 4.679, P = 0.026) were four independent factors differentiating PLC from intrapulmonary metastasis. All of these were included in the nomogram. The C-index of the nomogram for predicting probability was 0.82.

Conclusions

Incidence of malignant SPLs was fairly high in patients with history of malignancy. A nomogram including site and lymph node status of primary tumor, and spiculation and location of SPL might be a good tool for differentiating PLC from intrapulmonary metastasis preoperatively and guiding treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the national lung screening trial. N Engl J Med. 2013; 369(10):920–931.CrossRefPubMedPubMedCentral Aberle DR, DeMello S, Berg CD, et al. Results of the two incidence screenings in the national lung screening trial. N Engl J Med. 2013; 369(10):920–931.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Sayyouh M, Vummidi DR, Kazerooni EA. Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives. Expert Opin Med Diagn. 2013; 7(6):629–644.CrossRefPubMed Sayyouh M, Vummidi DR, Kazerooni EA. Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives. Expert Opin Med Diagn. 2013; 7(6):629–644.CrossRefPubMed
3.
Zurück zum Zitat Brader P, Abramson SJ, Price AP, et al. Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign? J Pediatr Surg. 2011; 46(4):729–735.CrossRefPubMedPubMedCentral Brader P, Abramson SJ, Price AP, et al. Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign? J Pediatr Surg. 2011; 46(4):729–735.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? Chest. 2007; 132(3):108–130.CrossRef Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? Chest. 2007; 132(3):108–130.CrossRef
5.
Zurück zum Zitat David Ost, Alan M Fein, Steven H Feinsilver, et al. The solitary pulmonary nodule. Respiration. 2015;90(2):160–172.CrossRef David Ost, Alan M Fein, Steven H Feinsilver, et al. The solitary pulmonary nodule. Respiration. 2015;90(2):160–172.CrossRef
6.
Zurück zum Zitat Deppen SA, Blume JD, Aldrich MC, et al. Predicting lung cancer prior to surgical resection in patients with lung nodules. J Thorac Oncol. 2014; 9(10):1477–1484.CrossRefPubMedPubMedCentral Deppen SA, Blume JD, Aldrich MC, et al. Predicting lung cancer prior to surgical resection in patients with lung nodules. J Thorac Oncol. 2014; 9(10):1477–1484.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997; 157(8):849–855.CrossRefPubMed Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997; 157(8):849–855.CrossRefPubMed
9.
Zurück zum Zitat Schultz EM, Sanders GD, Trotter PR, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008; 63(4):335–341.CrossRefPubMed Schultz EM, Sanders GD, Trotter PR, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008; 63(4):335–341.CrossRefPubMed
10.
Zurück zum Zitat Mery CM, Pappas AN, Bueno R, et al. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest. 2004; 125(6):2175–2181.CrossRefPubMed Mery CM, Pappas AN, Bueno R, et al. Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest. 2004; 125(6):2175–2181.CrossRefPubMed
11.
Zurück zum Zitat Grimes DA. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med. 2008; 149:273–275.CrossRefPubMed Grimes DA. The nomogram epidemic: resurgence of a medical relic. Ann Intern Med. 2008; 149:273–275.CrossRefPubMed
12.
Zurück zum Zitat Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006; 24:3967–3972.CrossRefPubMed Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006; 24:3967–3972.CrossRefPubMed
13.
Zurück zum Zitat Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer specific survival nomogram. J Clin Oncol. 2007; 25:1316–1322.CrossRefPubMed Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer specific survival nomogram. J Clin Oncol. 2007; 25:1316–1322.CrossRefPubMed
14.
Zurück zum Zitat Wierda WG, O’Brien S, Wang X, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007; 109:4679–4685.CrossRefPubMed Wierda WG, O’Brien S, Wang X, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007; 109:4679–4685.CrossRefPubMed
15.
Zurück zum Zitat Uderner M. Light and intermittent tobacco smokers. Rev Mal Respir. 2010; 27(10):1150–1163.CrossRef Uderner M. Light and intermittent tobacco smokers. Rev Mal Respir. 2010; 27(10):1150–1163.CrossRef
16.
Zurück zum Zitat GA Patterson. Pearson’s thoracic & esophageal surgery, 3rd Edn. Philadelphia: Churchill Livingstone; 2008. GA Patterson. Pearson’s thoracic & esophageal surgery, 3rd Edn. Philadelphia: Churchill Livingstone; 2008.
17.
Zurück zum Zitat Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011; 8(6):378–382.CrossRefPubMed Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011; 8(6):378–382.CrossRefPubMed
18.
Zurück zum Zitat Lo SS, Fakiris AJ, Teh BS, et al. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther. 2009; 9(5):621–635.CrossRefPubMed Lo SS, Fakiris AJ, Teh BS, et al. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther. 2009; 9(5):621–635.CrossRefPubMed
19.
Zurück zum Zitat Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005; 242(4):540–544.PubMedPubMedCentral Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg. 2005; 242(4):540–544.PubMedPubMedCentral
20.
Zurück zum Zitat Rena O, Danoli F, Boldorini R, et al. The solitary pulmonary nodule in patients with previous cancer history: results of surgical treatment. Eur J Surg Oncol. 2013; 39(11):1248–1253.CrossRefPubMed Rena O, Danoli F, Boldorini R, et al. The solitary pulmonary nodule in patients with previous cancer history: results of surgical treatment. Eur J Surg Oncol. 2013; 39(11):1248–1253.CrossRefPubMed
21.
Zurück zum Zitat Cahan WG. Multiple primary cancers, one of which is lung. Surg Clin North Am. 1969; 49(2):323–335.CrossRefPubMed Cahan WG. Multiple primary cancers, one of which is lung. Surg Clin North Am. 1969; 49(2):323–335.CrossRefPubMed
22.
Zurück zum Zitat Quint LE, Park CH, Iannettoni MD, et al. Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology. 2000; 217(1):257–261.CrossRefPubMed Quint LE, Park CH, Iannettoni MD, et al. Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology. 2000; 217(1):257–261.CrossRefPubMed
23.
Zurück zum Zitat Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115–132.CrossRefPubMed Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115–132.CrossRefPubMed
24.
Zurück zum Zitat Dai C, Shen J, Ren Y, et al. Choice of surgical procedure for patients with non-small-cell lung cancer ≤ 1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol. 2016; 34(26):3175–3182.CrossRefPubMed Dai C, Shen J, Ren Y, et al. Choice of surgical procedure for patients with non-small-cell lung cancer ≤ 1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol. 2016; 34(26):3175–3182.CrossRefPubMed
25.
Zurück zum Zitat Kothary N, Bartos JA, Hwang GL, et al. Computed tomography-guided percutaneous needle biopsy of indeterminate pulmonary pathology: efficacy of obtaining a diagnostic sample in immunocompetent and immunocompromised patients. Clin Lung Cancer. 2010; 11(4):251–256.CrossRefPubMed Kothary N, Bartos JA, Hwang GL, et al. Computed tomography-guided percutaneous needle biopsy of indeterminate pulmonary pathology: efficacy of obtaining a diagnostic sample in immunocompetent and immunocompromised patients. Clin Lung Cancer. 2010; 11(4):251–256.CrossRefPubMed
26.
Zurück zum Zitat Liu S, Wang R, Zhang Y, et al. Precise diagnosis of intrapulmonary frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma. J Clin Oncol. 2016; 34(4):307–313.CrossRefPubMed Liu S, Wang R, Zhang Y, et al. Precise diagnosis of intrapulmonary frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma. J Clin Oncol. 2016; 34(4):307–313.CrossRefPubMed
27.
Zurück zum Zitat Moldvay J, Jackel M, Bogos K, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004; 10:85–88.CrossRefPubMed Moldvay J, Jackel M, Bogos K, et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res. 2004; 10:85–88.CrossRefPubMed
28.
Zurück zum Zitat Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med. 2008; 132(3):384–396.PubMed Jagirdar J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med. 2008; 132(3):384–396.PubMed
30.
Zurück zum Zitat Ikai I, Arii S, Ichida T, et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res. 2005; 32(3):163–172.CrossRefPubMed Ikai I, Arii S, Ichida T, et al. Report of the 16th follow-up survey of primary liver cancer. Hepatol Res. 2005; 32(3):163–172.CrossRefPubMed
31.
Zurück zum Zitat Benoit L, Anusca A, Ortega-Deballon P, et al. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Eur J Surg Oncol. 2006; 32(5):583–587.CrossRefPubMed Benoit L, Anusca A, Ortega-Deballon P, et al. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Eur J Surg Oncol. 2006; 32(5):583–587.CrossRefPubMed
32.
Zurück zum Zitat Nordholm-Carstensen A, Wille-Jørgensen PA, Jorgensen LN, Harling H. indeterminate pulmonary nodules at colorectal cancer staging: a systematic review of predictive parameters for malignancy. Ann Surg Oncol. 2013; 20(12):4022–4030.CrossRefPubMed Nordholm-Carstensen A, Wille-Jørgensen PA, Jorgensen LN, Harling H. indeterminate pulmonary nodules at colorectal cancer staging: a systematic review of predictive parameters for malignancy. Ann Surg Oncol. 2013; 20(12):4022–4030.CrossRefPubMed
33.
Zurück zum Zitat Sortini A, Carcoforo P, Ascanelli S, et al. Significance of a single pulmonary nodule in patients with previous history of malignancy. Eur J Cardiothorac Surg. 2001; 20(6):1151–1155. Sortini A, Carcoforo P, Ascanelli S, et al. Significance of a single pulmonary nodule in patients with previous history of malignancy. Eur J Cardiothorac Surg. 2001; 20(6):1151–1155.
34.
Zurück zum Zitat Takahashi Y, Ikeda N, Nakajima J, et al. Prognostic analysis of surgical resection for pulmonary metastasis from hepatocellular carcinoma. World J Surg. 2016; 40(9):2178–2185.CrossRefPubMed Takahashi Y, Ikeda N, Nakajima J, et al. Prognostic analysis of surgical resection for pulmonary metastasis from hepatocellular carcinoma. World J Surg. 2016; 40(9):2178–2185.CrossRefPubMed
35.
Zurück zum Zitat Embun R, Rivas de Andrés JJ, Call S, et al. Causal model of survival after pulmonary metastasectomy of colorectal cancer: a nationwide prospective registry. Ann Thorac Surg. 2016; 101(5):1883–1890.CrossRefPubMed Embun R, Rivas de Andrés JJ, Call S, et al. Causal model of survival after pulmonary metastasectomy of colorectal cancer: a nationwide prospective registry. Ann Thorac Surg. 2016; 101(5):1883–1890.CrossRefPubMed
36.
Zurück zum Zitat Furuya K, Murayama S, Soeda H, et al. New classification of small pulmonary nodules by margin characteristics on high-resolution CT. Acta Radiol. 1999; 40(5):496–504.CrossRefPubMed Furuya K, Murayama S, Soeda H, et al. New classification of small pulmonary nodules by margin characteristics on high-resolution CT. Acta Radiol. 1999; 40(5):496–504.CrossRefPubMed
37.
Zurück zum Zitat Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007; 242(2):555–562.CrossRefPubMed Lindell RM, Hartman TE, Swensen SJ, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007; 242(2):555–562.CrossRefPubMed
38.
Zurück zum Zitat Zwirewich CV, Vedal S, Miller RR, Muler NL. Solitary pulmonary nodules: high-resolution CT and radiologic-pathologic correlation. Radiology. 1991; 179:469–476.CrossRefPubMed Zwirewich CV, Vedal S, Miller RR, Muler NL. Solitary pulmonary nodules: high-resolution CT and radiologic-pathologic correlation. Radiology. 1991; 179:469–476.CrossRefPubMed
Metadaten
Titel
Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?
verfasst von
Ke Jin, MD
Kexi Wang, MD
Huizhong Zhang, MD
Yuejiang Pan, MD
Dexiong Cao, MD
Minghui Wang, MD
Ju Chen, MD
Duoguang Wu, MD
Boshen Chen, MD
Xuan Xie, MD
Publikationsdatum
07.02.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6360-6

Weitere Artikel der Ausgabe 5/2018

Annals of Surgical Oncology 5/2018 Zur Ausgabe

Health Services Research and Global Oncology

Denis Parsons Burkitt, an Overlooked Surgical Oncologist

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.